H. Olesen

Properties and units in the clinical laboratory sciences. Part XVIII. Properties and units in clinical molecular biology (IUPAC Technical Report)

This document describes the introduction of the concept of property in the field of molecular biology for the presentation of results of clinical laboratory investigations of genes and mutations. It follows the IUPAC–IFCC systematic rules and attempts to create a common base for communication between the clinical laboratory sciences, the medical practitioner, and the molecular biology areas of knowledge. Because of the plethora of possible structural variations in the outcome of analysis, the designation of components is restricted to the symbols of genes as identified by the Human Genome Nomenclature Database (HUGO). The listing of properties having DNA as system comprises all symbols in the HUGO database except for symbols related to mitochondrial genes, while properties having RNA as system are included only when known to be in actual use. The detailed and accurate presentation of results is made by the laboratory performing the study, and it is recommended that the explicit guidelines given by Antonarakis and den Dunnen be adhered to. For electronic communication, a code (NPU) is allocated to each property identified. The complete list of properties, which is an integral part of this report, can be accessed at .

Properties and units in the clinical laboratory sciences. Part XII. Properties and units in clinical pharmacology and toxicology (Technical Report) (IFCC-IUPAC 1999)

The term designating a substance being an active ingredient of a drug may be a generic name, a nonproprietary name, a registered trade name, a fantasy name, or other. This causes difficulties in the transmission of requests and reports on properties for such substances in biological fluids to and from the clinical laboratories, and in the collating of this information from different sources. The document comprises a list of properties of drugs in biological fluids for use in electronic transmission systems. Systematic names are presented together with a code value for each.

Properties and units in the clinical laboratory sciences V. Properties and units in thrombosis and haemostasis (Technical Report)

For historical reasons, the elements of properties (terms) used in the nomenclature for properties in thrombosis and haemostasis differ according to “school” of thought. This hampers communication. In collaboration, The Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis and the Commission (Committee) of Nomenclature, Properties and Units, previously “Quantities and Units” have prepared a set of recommended systematic names for properties in that domain. For use in electronic transmission each property has been given a code value. The prefix to the code values has been changed from “QU” to “NPU” because of the change of name of the Commission (Committee).

International Society of Andrology1 and International Union of Pure and Applied Chemistry, Chemistry and Human Health Division, Clinical Chemistry Section, Commission on Nomenclature, Properties And Units (C-NPU)2 and International Federation of Clinical Chemistry Scientific Division, Committee on Nomenclature, Properties And Units (C-NPU)2: Properties and units in the clinical laboratory sciences XIII. Properties and units in reproduction and fertility (IUPAC–IFCC technical report 1997)

This document is the first recommendation on the presentation of properties in reproduction and fertility and their values in clinical laboratory sciences from The International Society of Andrology, IFCC and IUPAC. It forms part of the ongoing effort to standardise requests and reporting of laboratory data for transmission across cultural and linguistic domains, without attempting to standardise the language used by clinicians and laboratory practitioners. The document is accessible on Internet from C-NPU home page address: http://inet.uni-c.dk/ home/ifcc_iupac_cnpu.

International Federation of Clinical Chemistry1 and International Union of Pure and Applied Chemistry2: Properties and Units in the Clinical Laboratory Sciences VI. Properties and Units in IOC Prohibited Drugs (IFCC-IUPAC Recommendations 1997)

The term designating a substance being an active ingredient of a drug may be a generic name, a nonproprietary name, a registered trade name, a fantasy name or other. This causes difficulties in the transmission of request and report on such substances to and from the clinical laboratories, and in the collating of this information from different sources. The document comprises a list of properties of drugs of abuse in biological fluids as defined by the International Olympic Committee Medical Code for use in electronic transmission systems. Standard systematic names are presented with a code value for each. The coding schemes thus prepared are accessible on Internet from C-NPU Home page address: http://inet.uni-c.dk/ qukb7642.